Addeo A, Friedlaender A, Banna GL, Weiss GJ (2021) TMB or not TMB as a biomarker: that is the question. Crit Rev Oncol Hematol 163:103374

Article  PubMed  Google Scholar 

Ai L, Xu A, Xu J (2020) Roles of PD-1/PD-L1 pathway: signaling, cancer, and beyond. Adv Exp Med Biol 1248:33–59

Article  CAS  PubMed  Google Scholar 

Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV et al (2013) Signatures of mutational processes in human cancer. Nature. 500(7463):415–421

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayob AZ, Ramasamy TS (2018) Cancer stem cells as key drivers of tumour progression. J Biomed Sci 25(1):20

Article  PubMed  PubMed Central  Google Scholar 

Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O et al (2021) Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39(6):845–865.e7

Article  CAS  PubMed  Google Scholar 

Caso R, Sanchez-Vega F, Tan KS, Mastrogiacomo B, Zhou J, Jones GD et al (2020) The underlying tumor genomics of predominant histologic subtypes in lung adenocarcinoma. J Thorac Oncol 15(12):1844–1856

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castellanos E, Feld E, Horn L (2017) Driven by mutations: the predictive value of mutation subtype in EGFR-mutated non-small cell lung cancer. J Thorac Oncol 12(4):612–623

Article  PubMed  Google Scholar 

Ceppi P, Volante M, Novello S, Rapa I, Danenberg KD, Danenberg PV et al (2006) ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Ann Oncol 17(12):1818–1825

Article  CAS  PubMed  Google Scholar 

Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D et al (2017) Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18(1):248–262

Article  CAS  PubMed  Google Scholar 

Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378

Article  CAS  PubMed  PubMed Central  Google Scholar 

Denisenko TV, Budkevich IN, Zhivotovsky B (2018) Cell death-based treatment of lung adenocarcinoma. Cell Death Dis 9(2):117

Article  PubMed  PubMed Central  Google Scholar 

Deo RC (2015) Machine learning in medicine. Circulation. 132(20):1920–1930

Article  PubMed  PubMed Central  Google Scholar 

Feng H-M, Zhao Y, Yan W-J, Li B (2023) Genomic and immunogenomic analysis of three prognostic signature genes in LUAD. BMC Bioinform 24(1):19

Article  CAS  Google Scholar 

Genova C, Dellepiane C, Carrega P, Sommariva S, Ferlazzo G, Pronzato P et al (2021) Therapeutic implications of tumor microenvironment in lung cancer: focus on immune checkpoint blockade. Front Immunol 12:799455

Article  PubMed  Google Scholar 

Greener JG, Kandathil SM, Moffat L, Jones DT (2022) A guide to machine learning for biologists. Nat Rev Mol Cell Biol 23(1):40–55

Article  CAS  PubMed  Google Scholar 

Gubin MM, Vesely MD (2022) Cancer immunoediting in the era of immuno-oncology. Clin Cancer Res 28(18):3917–3928

Article  CAS  PubMed  Google Scholar 

Guo L, Shao W, Zhou C, Yang H, Yang L, Cai Q et al (2023) Neratinib for HER2-positive breast cancer with an overlooked option. Mol Med 29(1):134

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han T, Liu Y, Wu J, Bai Y, Zhou J, Hu C et al (2023) An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma. Sci Rep 13(1):5153

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A et al (2021) Integrated analysis of multimodal single-cell data. Cell 184(13):3573–3587.e29

Article  CAS  PubMed  PubMed Central  Google Scholar 

He L, Jang JH, Choi HG, Lee SM, Nan MH, Jeong SJ et al (2013) Oligomycin a enhances apoptotic effect of TRAIL through CHOP-mediated death receptor 5 expression. Mol Carcinog 52(2):85–93

Article  PubMed  Google Scholar 

Hu J, Song Y, Cai X, Halina H, Qiao K, Lu J et al (2023) A novel pyroptosis gene expression-based risk score for survival in gastric cancer. Front Endocrinol (Lausanne) 14:1120216

Article  PubMed  Google Scholar 

Jassim A, Rahrmann EP, Simons BD, Gilbertson RJ (2023) Cancers make their own luck: theories of cancer origins. Nat Rev Cancer 23(10):710–724

Article  CAS  PubMed  Google Scholar 

Jiang Y-Z, Ma D, Suo C, Shi J, Xue M, Hu X et al (2019) Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell 35(3):428–440.e5

Article  CAS  PubMed  Google Scholar 

Jin H, Wang L, Bernards R (2023) Rational combinations of targeted cancer therapies: background, advances and challenges. Nat Rev Drug Discov 22(3):213–234

Article  CAS  PubMed  Google Scholar 

Jin R, Wang X, Zang R, Liu C, Zheng S, Li H et al (2020) Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma. Cancer Lett 483:46–58

Article  CAS  PubMed  Google Scholar 

Kay FU, Kandathil A, Batra K, Saboo SS, Abbara S, Rajiah P (2017) Revisions to the tumor, node, metastasis staging of lung cancer (8th edition): rationale, radiologic findings and clinical implications. World J Radiol 9(6):269–279

Article  PubMed  PubMed Central  Google Scholar 

Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B et al (2023) Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer 22(1):40

Article  PubMed  PubMed Central  Google Scholar 

Lee D, Park Y, Kim S (2021) Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches. Brief Bioinform 22(3):bbaa188

Lentz RW, Colton MD, Mitra SS, Messersmith WA (2021) Innate immune checkpoint inhibitors: the next breakthrough in medical oncology? Mol Cancer Ther 20(6):961–974

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu X, Meng J, Su L, Jiang L, Wang H, Zhu J et al (2021b) Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies. Clin Transl Med 11(12):e601

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu X, Meng J, Zhou Y, Jiang L, Yan F (2021a) MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics. 36(22-23):5539–5541

Article  PubMed  Google Scholar 

Ma C, Wu M, Ma S (2022) Analysis of cancer omics data: a selective review of statistical techniques. Brief Bioinform 23(2)

Madeddu C, Donisi C, Liscia N, Lai E, Scartozzi M, Macciò A (2022) EGFR-mutated non-small cell lung cancer and resistance to immunotherapy: role of the tumor microenvironment. Int J Mol Sci 23(12):6489